ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - abrocitinib - טבליות מצופות פילם - abrocitinib 100 mg - abrocitinib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - abrocitinib - טבליות מצופות פילם - abrocitinib 200 mg - abrocitinib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - abrocitinib - טבליות מצופות פילם - abrocitinib 50 mg - abrocitinib

ישראל - עברית - Ministry of Health

novartis israel ltd - ceritinib - קפסולות ג'לטין קשיחות - ceritinib 150 mg - ceritinib

ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 150 mg - capmatinib

ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 200 mg - capmatinib

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

kamada ltd - aprotinin 10000 kiu / 1 ml - solution for injection - aprotinin - protosol is used in adults in the treatment and prophylaxis of disorders in which inhibition of proteolytic enzymes is indicated: for the early treatment of states of shock. for the prevention of postoperative or post-traumatic complications. to reduce major blood loss in patients undergoing surgery involving cardiopulmonary bypass.

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - aprotinin acetate; calcium chloride dihydrate; human fibrinogen; human thrombin - calcium chloride dihydrate 40 mcmol/ml; human thrombin 500 iu / 1 ml; aprotinin acetate 3000 kiu / 1 ml; human fibrinogen 91 mg / 1 ml - combinations

ישראל - עברית - Ministry of Health

sanofi israel ltd - dupilumab - תמיסה להזרקה - dupilumab 150 mg/ml - dupilumab